Graniarc 1mg Injection
Marketer
Arco Lifesciences
Salt Composition
Granisetron (1mg)
Overview Graniarc 1mg Injection
Oncaspar 1mg Injection is an antiemetic medication frequently used to manage nausea and vomiting resulting from surgery, cancer chemotherapy, or radiation therapy. Oncaspar 1mg Injection does not alleviate other adverse effects of cancer treatments. Administration requires healthcare professional oversight and adherence to prescribed dosage. Continued injections are crucial until medically discontinued. Subsequently, oral medication may replace injections. Common side effects include injection site discomfort, headache, constipation, diarrhea, and fatigue. These usually subside upon treatment cessation; however, persistent or bothersome symptoms warrant consultation with your physician for management strategies. Prior to commencing treatment, inform your physician of any heart, liver, or gastrointestinal obstruction issues. Also disclose all concurrent medications, particularly those for epilepsy, cardiac conditions, cancer, or depression, as potential interactions exist. Pregnant or breastfeeding individuals should seek healthcare professional guidance.
Uses of Graniarc 1mg Injection
Chemotherapy-induced emesis
Major Benefits of Graniarc 1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Graniarc 1mg Injection:
- Injection site pain
- Constipation
- Diarrhea
- Headache
- Weakness
- Insomnia (difficulty in sleeping)
How to use Graniarc 1mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Graniarc 1mg Injection works:
Graniarc 1mg injection is an anti-nausea drug that counteracts the effects of serotonin, a neurotransmitter triggering nausea and vomiting. This action is particularly beneficial in managing chemotherapy-induced or post-surgical emesis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption with Graniarc 1mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Graniarc 1mg Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The administration of Graniarc 1mg Injection while breastfeeding appears to pose minimal risk. Available data from human studies indicate negligible harm to the infant.
DrivingSAFE
Driving ability is typically unaffected by a 1mg Graniarc injection.
KidneySAFE IF PRESCRIBED
In individuals with impaired kidney function, Graniarc 1mg Injection appears to be well-tolerated. Existing evidence indicates dose modification may not be necessary, however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Graniarc 1mg Injection in individuals with hepatic impairment is likely safe. Available evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Graniarc 1mg Injection :
Should you forget a Graniarc 1mg Injection, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Graniarc 1mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Indazole-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | 5-HT3 receptor blockers |
3,018 People bought this recently